克隆神经干细胞在帕金森病实验中的治疗用途
Anna Nelke1,2,3, Silvia García-López4,5,6, Javier R Caso7
1Unit of Molecular Neuropathology, Physiological and pathological processes Program, Centro de Biología Molecular Severo Ochoa UAM-CSIC, Calle Nicolás Cabrera, 1, Madrid, 28049, Spain. anna.nelke@dpag.ox.ac.uk.
Stem cell research & therapy
|October 10, 2024
概括
人类神经干细胞 (hNSCs) 在帕金森病 (PD) 治疗方面表现有前途. 在PD小鼠模型中,移植hVM1克隆32个细胞恢复了多巴胺通路并改善了神经发生.
科学领域:
- 神经科学是一个神经科学.
- 再生医学是一种再生医学.
- 细胞生物学 细胞生物学
背景情况:
- 帕金森病 (PD) 是一种常见的神经退行性疾病,其特征是多巴胺基神经元损失.
- 目前的PD治疗可以控制症状,但不能修复受损的神经元.
- 细胞替代疗法 (CRT) 提供了PD的潜力,但需要合适的细胞系.
研究的目的:
- 评估hVM1克隆32的治疗潜力,人类神经干细胞系,在帕金森病小鼠模型中.
- 评估hNSC移植对PD神经保护和功能恢复的影响.
主要方法:
- 成年雄性小鼠使用MPTP诱导帕金森病.
- 小鼠接受了hVM1克隆32细胞或缓冲对照的条纹移植.
- 移植后四个月进行了行为测试和组织学分析.
主要成果:
- 在PD小鼠中,hVM1克隆32细胞移植挽救了多巴胺基尼格罗斯特里亚特人群.
- 与对照组相比,移植hNSCs的小鼠表现出运动和神经系统改善的趋势.
- 移植促进了神经发生,并表明了局部恢复机制.
结论:
- 移植hVM1克隆32个细胞在帕金森病小鼠模型中显示出神经保护作用.
- 这项研究支持治疗帕金森病的细胞替代疗法的疗效.
- 恢复多巴胺基通路和海马神经发生突出显示了CRT的潜力.
相关概念视频
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
Parkinson's Disease: Treatment
231
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
231
Parkinson's Disease: Overview
487
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
487
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Induced Pluripotent Stem Cells
21.8K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
21.8K


